Latest filing published 27 Jan 2025 for Pliant Therapeutics, INC..
Filing timeline
BuySaleInsider track record
Eric Lefebvre: trading record in brief
Eric Lefebvre (senior executive) discloses dealings in Pliant Therapeutics, Inc. to SEC (Form 4). In total, 23 filings cover trades dated from 18 December 2020 to 23 January 2025.
No open-market purchase appears, only 16 sales worth €4.6M. Other entries cover 7 share grants. Since January 2025: no purchases and 1 sale on the market.
The latest filing, published on 27 January 2025, reports a share grant in Pliant Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Eric Lefebvre
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 45,650 shares0Common StockSEC:0001746473-25-000013:0
- 18,478 shares@ US$11.20115.5% of flowCommon StockSEC:0001746473-25-000003:0
- 12,319 shares@ US$11.563.6% of flowCommon StockSEC:0001746473-24-000129:0
- 24,063 shares0Common StockSEC:0001746473-24-000119:0
- 42,900 shares0Common StockSEC:0001746473-24-000017:0
- 10,295 shares@ US$17.234.4% of flowCommon StockSEC:0001746473-24-000002:0
- 22,321 shares@ US$18.00919.8% of flowCommon StockSEC:0001209191-23-042831:0
- 43,750 shares0Common StockSEC:0001209191-23-042660:0
- 11,245 shares@ US$26.52097.5% of flowCommon StockSEC:0001209191-23-022374:0
- 21,874 shares0Common StockSEC:0001209191-23-021921:0
- 57,000 shares0Common StockSEC:0001140361-23-003178:0
- 67,500 shares@ US$34.483458.5% of flowCommon StockSEC:0001140361-23-002784:0
- 10,887 shares@ US$19.10Common StockSEC:0001140361-22-046569:1
- 21,876 shares0Common StockSEC:0001140361-22-046569:0
- 5,000 shares@ US$25.04823.4% of flowCommon StockSEC:0001209191-22-054747:0
- 3,000 shares@ US$20.001.6% of flowCommon StockSEC:0001567619-22-013995:0
- 22 shares@ US$30.230.0% of flowCommon StockSEC:0001209191-21-042577:2
- 3,728 shares@ US$29.43Common StockSEC:0001209191-21-042577:1
- 8,750 shares@ US$28.62155.7% of flowCommon StockSEC:0001209191-21-042577:0
- 11,365 shares@ US$39.38Common StockSEC:0001209191-21-022161:0
- 1,135 shares@ US$39.78Common StockSEC:0001209191-21-022161:1
- 6,788 shares@ US$26.17Common StockSEC:0000899243-20-034780:0
- 5,712 shares@ US$26.98Common StockSEC:0000899243-20-034780:1
23 of 23 declarations